Institutions / Omega Fund Management, LLC

Omega Fund Management, LLC

CIK 1637359 · Institution · as of Dec 31, 2025
Portfolio value
$286.52M
Positions
11
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Nuvation Bio Inc.NUVBCommon Stock$72.41M8,081,08925.3%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$41.19M3,289,66114.4%
Beta Bionics, Inc.—$40.10M1,316,18314.0%
Bicara Therapeutics Inc.—$37.10M2,204,65012.9%
Kestra Med Technologies Ltd—$36.43M1,373,59112.7%
Upstream Bio, Inc.UPBCommon Stock$36.01M1,326,29312.6%
enGene Therapeutics Inc.—$7.91M876,3572.8%
Alumis Inc.ALMSCommon Stock$6.38M653,2232.2%
Sana Biotechnology, Inc.—$3.43M843,7501.2%
ImageneBio, Inc.IMACommon Stock$3.14M455,3611.1%
Replimune Group, Inc.—$2.42M248,6720.8%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.